The use of hyperbaric oxygen therapy to treat chronic wounds: A review

Wound Repair Regen. May-Jun 2008;16(3):321-30. doi: 10.1111/j.1524-475X.2008.00372.x.

Abstract

Chronic wounds, defined as those wounds which fail to proceed through an orderly process to produce anatomic and functional integrity, are a significant socioeconomic problem. A wound may fail to heal for a variety of reasons including the use of corticosteroids, formation of squamous cell carcinoma, persistent infection, unrelieved pressure, and underlying hypoxia within the wound bed. Hypoxia appears to inhibit the wound healing process by blocking fibroblast proliferation, collagen production, and capillary angiogenesis and to increase the risk of infection. Hyperbaric oxygen therapy (HBOT) has been shown to aid the healing of ulcerated wounds and demonstrated to reduce the risk of amputation in diabetic patients. However, the causal reasons for the response of the underlying biological processes of wound repair to HBOT, such as the up-regulation of angiogenesis and collagen synthesis are unclear and, consequently, current protocols remain empirical. Here we review chronic wound healing and the use of hyperbaric oxygen as an adjunctive treatment for nonhealing wounds. Databases including PubMed, ScienceDirect, Blackwell Synergy, and The Cochrane Library were searched for relevant phrases including HBOT, HBO/HBOT, wound healing, and chronic/nonhealing wounds/ulcers.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Chronic Disease
  • Clinical Protocols
  • Fibroblasts / immunology
  • Homeostasis / immunology
  • Humans
  • Hyperbaric Oxygenation*
  • Models, Theoretical
  • Oxygen / immunology
  • Treatment Outcome
  • Wound Healing / immunology
  • Wounds and Injuries / immunology
  • Wounds and Injuries / therapy*

Substances

  • Oxygen